Advertisement

Topics

PhotoCure Company Profile

22:37 EDT 24th September 2017 | BioPortfolio

PhotoCure is engaged in the research and development of novel therapeutics and diagnostics and related medical devices based on its proprietary photodynamic therapy (PDT) technologies.

PDT is a two step process involving the application of a drug known as a photosensitiser followed by controlled exposure to a selective light source that activates the drug. In addition, PhotoCure is employing photodynamic technology to develop products for the diagnosis of diseases, a process known as photodynamic diagnosis (PD).



In addition to its lead product, Metvix®, which has received regulatory marketing authorisation approval, PhotoCure has three core PDT/PD platform technologies; Photosensitisers, Photochemical synergism and Photochemical internalisation. PhotoCure has a pipeline of follow-on products and technologies.

Location

Hoffsveien 48
Oslo
0377
Norway

Contact

Phone: +47 22 06 22 10
Fax: +47 22 06 22 18
Email: vh@photocure.no


News Articles [11 Associated News Articles listed on BioPortfolio]

Photocure (PHO) - Phase III surveillance trial successful

Edison Investment Research - Pharmaceutical & healthcare - Photocure: Photocure presented the findings of from its Phase III clinical trial of Hexvix/Cysview for bladder cancer surveillance at the Ame...

Photocure (PHO) - A strong quarter in the US

Edison Investment Research - Pharmaceutical & healthcare - Photocure: Photocure announced results for Q117 with 9% growth for the Hexvix/Cysview franchise compared to Q116. The US was a major driver, ...

Photocure (PHO) - Positive CMS draft rule change

Edison Investment Research - Pharmaceutical & healthcare - Photocure: Photocure announced results for Q217 with 10% growth for the Hexvix/Cysview franchise compared to Q216. The US was a major driver,...

Photocure ASA 2017 Q2 - Results - Earnings Call Slides

PhotoCure ASA (PHCUF) Updates on Bladder Cancer - Slideshow

PhotoCure: Results For The First Quarter Of 2017

  Life Sciences Jobs   ...

Positive data from Phase 3 US Blue Light Cystoscopy with Cysview® study presented at AUA 2017 meeting in Boston

PRINCETON, N.J., May 14, 2017 /PRNewswire/ -- Photocure Inc., (Photocure, PHO: OSE), today announced that new Phase 3 study results with Blue Light Flexible Cystoscopy (BLFC™) with Hexvix®/Cys...

PhotoCure: Results For Second Quarter And First Half Year Of 2017

  Life Sciences Jobs   ...

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Cysview [Photocure Inc.]

These highlights do not include all the information needed to use Cysview safely and effectively. See full prescribing information for Cysview. Cysview (hexaminolevulinate hydrochloride), for Intraves...

Metvixia™ (methyl aminolevulinate) cream, 16.8%for topical use only. not for ophthalmic, oral, or intravaginal usemust be dispensed to and applied by a physician. [Penn Pharmaceutical Services Ltd.]

METVIXIA™ (methyl aminolevulinate) Cream, 16.8%For Topical Use Only. Not for Ophthalmic, Oral, or Intravaginal UseMust be dispensed to and applied by a physician.

Cysview [GE Healthcare Inc.]

These highlights do not include all the information needed to use Cysview safely and effectively. See full prescribing information for Cysview. Cysview (hexaminolevulinate hydrochloride), for Intraves...

Metvixia [Galderma Laboratories, L.P.]

These highlights do not include all the information needed to use METVIXIA safely and effectively.See full prescribing information for METVIXIA. METVIXIA™ (methyl aminolevulinate) Cream, 16.8%For To...

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol

This pilot study will try to minimize the pain during exposure to a new red light source (RhodoLED®, Biofrontera Bioscience GmbH, Leverkusen, Germany) used for PDT without compromising it...

Companies [2 Associated Companies listed on BioPortfolio]

PhotoCure

PhotoCure is engaged in the research and development of novel therapeutics and diagnostics and related medical devices based on its proprietary photodynamic therapy (PDT) technologies. PDT is a two st...

PhotoCure ASA

PhotoCure ASA is a Norwegian company that develops and sells pharmaceuticals and medical devices based on its proprietary photodynamic therapy (PDT) technologies, targeting key dermatology and oncolog...

More Information about "PhotoCure" on BioPortfolio

We have published hundreds of PhotoCure news stories on BioPortfolio along with dozens of PhotoCure Clinical Trials and PubMed Articles about PhotoCure for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PhotoCure Companies in our database. You can also find out about relevant PhotoCure Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record